Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers
Taha, Karim; van de Leur, Rutger R.; Vessies, Melle; Mast, Thomas P.; Cramer, Maarten J.; Cauwenberghs, Nicholas; Verstraelen, Tom E.; de Brouwer, Remco; Doevendans, Pieter A.; Wilde, Arthur; Asselbergs, Folkert W.; van den Berg, Maarten P.; D’hooge, Jan; Kuznetsova, Tatiana; Teske, Arco J.; van Es, René
(2023) International Journal of Cardiovascular Imaging, volume 39, issue 11, pp. 2149 - 2161
(Article)
Abstract
Echocardiographic deformation curves provide detailed information on myocardial function. Deep neural networks (DNNs) may enable automated detection of disease features in deformation curves, and improve the clinical assessment of these curves. We aimed to investigate whether an explainable DNN-based pipeline can be used to detect and visualize disease features in
... read more
echocardiographic deformation curves of phospholamban (PLN) p.Arg14del variant carriers. A DNN was trained to discriminate PLN variant carriers (n = 278) from control subjects (n = 621) using raw deformation curves obtained by 2D-speckle tracking in the longitudinal axis. A visualization technique was used to identify the parts of these curves that were used by the DNN for classification. The PLN variant carriers were clustered according to the output of the visualization technique. The DNN showed excellent discriminatory performance (C-statistic 0.93 [95% CI 0.87–0.97]). We identified four clusters with PLN-associated disease features in the deformation curves. Two clusters showed previously described features: apical post-systolic shortening and reduced systolic strain. The two other clusters revealed novel features, both reflecting delayed relaxation. Additionally, a fifth cluster was identified containing variant carriers without disease features in the deformation curves, who were classified as controls by the DNN. This latter cluster had a very benign disease course regarding development of ventricular arrhythmias. Applying an explainable DNN-based pipeline to myocardial deformation curves enables automated detection and visualization of disease features. In PLN variant carriers, we discovered novel disease features which may improve individual risk stratification. Applying this approach to other diseases will further expand our knowledge on disease-specific deformation patterns. Graphical abstract: [Figure not available: see fulltext.] Overview of the deep neural network-based pipeline for feature detection in myocardial deformation curves. Firstly, phospholamban (PLN) p.Arg14del variant carriers and controls were selected and a deep neural network (DNN) was trained to detect the PLN variant carriers. Subsequently, a clustering-based approach was performed on the attention maps of the DNN, which revealed 4 distinct phenotypes of PLN variant carriers with different prognoses. Moreover, a cluster without features and a benign prognosis was detected.
show less
Download/Full Text
Keywords: Cardiomyopathy, Clustering, Deep learning, Deformation imaging, Phospholamban, Strain, Radiology Nuclear Medicine and imaging, Cardiology and Cardiovascular Medicine
ISSN: 1569-5794
Publisher: Springer Netherlands
Note: Funding Information: This study was financed by the The Netherlands Organisation for Health Research and Development (ZonMw) with grant number 104021004, the Dutch Heart Foundation (2019B011, CVON2018-30 PREDICT2 and CVON2015-12 eDETECT), the PLN Genetic Heart Disease Foundation and the Leducq Foundation (CURE-PLaN coordinated by prof. dr. Doevendans). The Research Unit Hypertension and Cardiovascular Epidemiology (Leuven, Belgium; FLEMENGHO cohort) currently receives support from the Fonds voor Wetenschappelijk Onderzoek (FWO-Flanders; grants 1225021N, 1S07421N and G0C5319N). Prof. Dr. Asselbergs is supported by UCL Hospitals NIHR Biomedical Research Centre. Funding Information: We gratefully acknowledge the support of NVIDIA Corporation with the donation of the Titan Xp GPU used for this research. Publisher Copyright: © 2023, The Author(s).
(Peer reviewed)